A case of encapsulating peritoneal sclerosis in a patient with chronic schistosomiasis.

Autor:	Fragkou PC; 4th Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, 'Attikon' University Hospital, 1 Rimini Str, Chaidari, Athens, 12462, Greece., Karofylakis E; 4th Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, 'Attikon' University Hospital, 1 Rimini Str, Chaidari, Athens, 12462, Greece., Oikonomopoulos N; 2nd Laboratory of Radiology, Medical School, National and Kapodistrian University of Athens, 'Attikon' University Hospital, 1 Rimini Str, Chaidari, Athens, 12462, Greece., Piperaki ET; Parasitology Unit, Microbiology Laboratory of Medical School, National and Kapodistrian University of Athens, Mikras Asias 75, Goudi, Athens, 11527, Greece., Tsiodras S; 4th Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, 'Attikon' University Hospital, 1 Rimini Str, Chaidari, Athens, 12462, Greece., Kavvatha D; 4th Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, 'Attikon' University Hospital, 1 Rimini Str, Chaidari, Athens, 12462, Greece.
Jazyk:	angličtina
Zdroj:	IDCases [IDCases] 2021 Apr 12; Vol. 24, pp. e01123. Date of Electronic Publication: 2021 Apr 12 (Print Publication: 2021).
DOI:	10.1016/j.idcr.2021.e01123
Abstrakt:	Encapsulating peritoneal sclerosis (EPS) is a debilitating condition, mainly associated with long-term peritoneal dialysis, where up-regulation of intra-abdominal inflammatory pathways leads to a fibrocollagenous peritoneal membrane formation resembling a cocoon. EPS causes intestinal encapsulation leading to bowel obstruction and dilatation. Chronic schistosomiasis is characterized by dysregulation of pro-inflammatory and anti-inflammatory cytokines. EPS has never been reported before in patients with chronic schistosomiasis. We report the first, to our knowledge, case of a 57-year-old male originated from Burkina Faso with chronic intestinal and urogenital schistosomiasis and EPS. Although causality cannot be established solely by this case, we hypothesize that EPS may be the result of chronic inflammatory activation, due to immune dysregulation driven by chronic schistosomiasis. The potential pathogenetic linkage between these two conditions should be further explored. Competing Interests: The authors report no declarations of interest. (© 2021 The Author(s).)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu